The role of transglutaminase family in central nervous system diseases: From molecular mechanisms to therapeutic targets

Genes and Diseases · Published 2026-08-01 · DOI 10.1016/j.gendis.2026.102392

Free full text

Authors (6)

Yang Xue, Zhongxuan Wang, Yawen Yang, Siyue Chen, Xiaohang Qian, Huidong Tang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Xue, Y., Wang, Z., Yang, Y., et al. (2026). The role of transglutaminase family in central nervous system diseases: From molecular mechanisms to therapeutic targets. Genes and Diseases. https://doi.org/10.1016/j.gendis.2026.102392

Related articles

• Immune therapies in coeliac disease and food allergies: Advances, challenges, and opportunities · Seminars in Immunology · 2025 · Cites or is cited by this article
• Charting the landscape of microbiota in bladder cancer: Molecular mechanisms and therapeutic implications · Genes and Diseases · 2026 · Same journal
• Mitochondrial DNA mutation associations with ERK/MAPK inhibitor sensitivity in cancer · Genes and Diseases · 2026 · Same journal
• Role of post-translational modifications in cancer metabolic reprogramming · Genes and Diseases · 2026 · Same journal
• SASH3 mutations cause monogenic inflammatory bowel diseases by disrupting NF-κB and mTORC1 pathways · Genes and Diseases · 2026 · Same journal
• Xbp1s regulates cardiac fibrosis by transcriptionally activating Stat3 in mice · Genes and Diseases · 2026 · Same journal
• Loss of CCDC3 alleviates MAFLD and metabolic aging of mice through enhanced AGXT-associated hepatocyte glycine metabolism · Genes and Diseases · 2026 · Same journal
• Enhancer/HMGCS1 axis-mediated lipid metabolism remodeling promotes TAM resistance in ER+ breast cancer · Genes and Diseases · 2026 · Same journal
• Integrative genetic and transcriptomic analyses reveal alternative carcinogenetic pathways in basal cell carcinoma · Genes and Diseases · 2026 · Same journal
• SR-BI deficiency inhibits melanogenesis by attenuating the PKA/CREB signaling axis: Implications for vitiligo · Genes and Diseases · 2026 · Same journal